Delivery Order SPE2DB20D7059-SPE2DB25FGSB0
- Not listed
- The Defense Logistics Agency awarded a $5,940.28 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units). This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,399.15 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 microgram/day contraceptive patches (3-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,082.94 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,884.42 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count package) on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,885.09 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit package) on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,926.84 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (3-pack units). This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.57 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 11, 2025. The delivery location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count package) under a firm fixed-price contract valued at $4,472.88. This non-set-aside competitive award is classified as a delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.42 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (3-pack). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGSB0Delivery Order
The Defense Logistics Agency awarded a $1,719.90 delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999.9 billion prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to military healthcare programs worldwide. This specific delivery order for contraceptive patches supports the Defense Health Agency and other government healthcare systems through the established contract framework, demonstrating AmerisourceBergen's critical role as a federal pharmaceutical vendor serving defense and military medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/13/25 |